Medical device technologies market seen topping $749 billion by 2030

By AI, Created 1:40 PM UTC, May 25, 2026, /AGP/ – The global medical device technologies market is projected to reach $749.15 billion by 2030, growing at a 5% CAGR from 2025, according to The Business Research Company. North America is expected to lead the market, while diagnostic imaging is forecast to remain the largest product segment.

Why it matters: - The market forecast points to sustained demand for devices used in diagnosis, monitoring, treatment and remote care. - The report projects the category will represent about 51% of the broader healthcare technology market by 2030. - The market is expected to account for nearly 5% of the total information technology industry value by 2030.

What happened: - The Business Research Company projected the global medical device technologies market will reach $749.15 billion by 2030. - The report said the market will grow from its 2025 level at a 5% compound annual growth rate. - North America is forecast to be the largest regional market in 2030 at $262 billion, up from $209 billion in 2025. - The USA is projected to be the largest country market in 2030 at $234 billion, rising from $187 billion in 2025. - The report identifies diagnostic imaging as the largest product segment in 2030, at 19% of the market or $139 billion. - The company published a free sample request and a detailed market report.

The details: - The market is segmented by type into molecular diagnostics, diagnostic imaging, non-invasive monitoring, drug delivery, mobility aid technologies, micro fluids and mems, bio-implants, biomaterials, minimal or non-invasive surgery and telemedicine. - The market is segmented by application into cardiology, orthopedics, oncology, neurology, respiratory and other applications. - The market is segmented by end user into hospitals, clinics, ambulatory surgical centers, diagnostics centers, research organizations and other end users. - Diagnostic imaging is supported by rising chronic and cardiovascular disease prevalence. - Diagnostic imaging demand is also being driven by early and accurate diagnosis, AI-enabled imaging systems, advances in MRI, CT, ultrasound and X-ray technologies, infrastructure spending and more image-guided procedures. - North America’s growth is linked to high healthcare spending, a strong manufacturing base, faster adoption of advanced diagnostic and therapeutic technologies, regulatory support, chronic disease prevalence and demand for minimally invasive and connected care. - The USA’s growth is tied to higher healthcare spending, adoption of advanced diagnostic and surgical technologies, research and development investment, minimally invasive procedures, digital health, connected care and hospital modernization.

Between the lines: - The forecast suggests medical devices are becoming more central to broader healthcare technology spending, not just a standalone category. - Growth is concentrated in products that reduce hospital dependence, improve early diagnosis and support digital workflows. - The largest opportunities appear to be in imaging, molecular diagnostics, monitoring and telemedicine, which together reflect a shift toward connected and home-based care. - The report also highlights chronic disease management as a durable demand driver, which supports recurring use rather than one-time purchases.

What’s next: - The report expects chronic disease prevalence, technological innovation and home healthcare demand to keep driving market growth through 2030. - The Business Research Company projects chronic disease growth will add 2.1% annual market growth. - Technological advancements and digital integration are projected to contribute about 1.8% annual growth. - Demand for home healthcare and remote monitoring is projected to contribute about 1.6% annual growth. - Over the next five years from 2025 to 2030, the molecular diagnostics market is projected to add $25 billion and diagnostic imaging $33 billion. - Other projected gains include $21 billion for non-invasive monitoring, $16 billion for drug delivery, $10 billion for mobility aid technologies, $7 billion for micro fluids and mems, $21 billion for bio-implants, $5 billion for biomaterials, $18 billion for minimal or non-invasive surgery and $12 billion for telemedicine.

The bottom line: - Medical device technologies are on track for steady, broad-based expansion, led by imaging, connected care and chronic disease management.